Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis
- PMID: 38824212
- DOI: 10.1007/s11136-024-03670-8
Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis
Abstract
Introduction: Ankylosing spondylitis (AS) is a chronic condition that requires lifelong treatment and results in a serious disease burden. Health state utility values (HSUVs) are a valuable tool for quantifying this burden and conducting cost-utility analysis.
Objective: We conducted a systematic review and meta-analysis to obtain estimates of HSUVs in patients with AS, explored potential sources of heterogeneity, and compared pooled patient HSUVs with population norms.
Method: We searched PubMed, Embase, Web of science, Cochrane database and Scopus until July, 2023 to obtain eligible studies. The methodological quality of the included studies was assessed using the ROBINS-I checklist.
Results: Forty-two publications involving 11,354 participants were included in this systematic review. The most commonly used instrument is the EQ-5D (38 studies). The estimated HSUVs for patients with AS from all available studies was pooled as 0.62 (95% CI 0.59 to 0.65). The pooled mean utility estimates from the random effects meta-analysis for SF-6D, EQ-5D-3L, EQ-5D-5L, and HUI3 were 0.65 (95% CI 0.62,0.68), 0.63 (95% CI 0.59,0.66), 0.60 (95% CI 0.42,0.79), and 0.48 (95% CI 0.43,0.53), respectively. For the EQ-5D-3L we conducted stratified meta-analyses and meta-regression based on key subgroups. The pooled estimates of EQ-5D-3L were lower for patients published before 2010, with high disease activity, long duration of disease, and in developed countries.
Conclusion: Pooled estimates of HSUVs for people with AS were substantially lower than population norms. These estimates provide robust evidence that can inform the economic evaluation of new therapies for individuals with AS.
Keywords: Ankylosing Spondylitis; Health state utility values; Meta-analysis; Systematic review.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2022 Jul 5;11(13):e024296. doi: 10.1161/JAHA.121.024296. Epub 2022 Jun 22. J Am Heart Assoc. 2022. PMID: 35730598 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.Health Qual Life Outcomes. 2022 Dec 23;20(1):169. doi: 10.1186/s12955-022-02067-w. Health Qual Life Outcomes. 2022. PMID: 36564800 Free PMC article. Review.
-
Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis.Value Health Reg Issues. 2023 Mar;34:14-22. doi: 10.1016/j.vhri.2022.09.005. Epub 2022 Nov 11. Value Health Reg Issues. 2023. PMID: 36371899
-
Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.Health Qual Life Outcomes. 2021 Mar 18;19(1):94. doi: 10.1186/s12955-021-01723-x. Health Qual Life Outcomes. 2021. PMID: 33736649 Free PMC article.
References
-
- Braun, J., & Sieper, J. (2007). Ankylosing spondylitis. Lancet, 369(9570), 1379–1390. https://doi.org/10.1016/S0140-6736(07)60635-7 - DOI - PubMed
-
- Taurog, J. D., Chhabra, A., & Colbert, R. A. (2016). Ankylosing spondylitis and axial spondyloarthritis. The New England Journal of Medicine, 374(26), 2563–2574. https://doi.org/10.1056/NEJMra1406182 - DOI - PubMed
-
- Wang, R., & Ward, M. M. (2018). Epidemiology of axial spondyloarthritis: An update. Current Opinion in Rheumatology, 30(2), 137–143. https://doi.org/10.1097/BOR.0000000000000475 - DOI - PubMed - PMC
-
- Dean, L. E., Jones, G. T., MacDonald, A. G., Downham, C., Sturrock, R. D., & Macfarlane, G. J. (2014). Global prevalence of ankylosing spondylitis. Rheumatology (Oxford, England), 53(4), 650–657. https://doi.org/10.1093/rheumatology/ket387 - DOI - PubMed
-
- Tu, L., Xie, Y., Liao, Z., Jiang, Y., Lv, Q., Cao, S., Wei, Q., & Gu, J. (2020). Cost of illness, quality of life, and work outcomes in active ankylosing spondylitis patients treated with adalimumab in China. Frontiers in Public Health, 8, 602334. https://doi.org/10.3389/fpubh.2020.602334 - DOI - PubMed - PMC
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials